Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate mofetil for Takayasu's arteritis
ChiCTR-OPC-16008907Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mycophenolate mofetil in Takayasu arteritis (TAK) (2 arms), sponsored by Peking Union Medical College. Primary endpoint: Percentage of patients with full and partial effectiveness. Planned start Aug 2016; status: not yet recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
Takayasu arteritis (TAK)
Beyond the preview
Go deeper on ChiCTR-OPC-16008907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16008907.